Wildflower Health
PrivateLast Round
Series D
Mar 8, 2022
Total Funding Raised
$42.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Wildflower Health operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series D round in March 2022.
Wildflower Health is a health technology company that provides a mobile health engagement platform to connect families with personalized health resources and support for healthy pregnancies and overall family well-being.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Vertical SaaS, Healthcare Analytics, Telemedicine
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wildflower Health Comparables
Compare Wildflower Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Babyscripts | 86% | |
| Mahmee | 86% | |
| Delfina Care Inc | 84% |
For institutional investors. Book with your work email.
Wildflower Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 8, 2022 | ||||
| Debt | Apr 1, 2020 | ||||
| Series C | Mar 7, 2018 | ||||
| Series B | Jun 25, 2015 | ||||
| Series A | Dec 12, 2013 | ||||
Seed | Oct 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wildflower Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Capital | Series A, Series B |
| KMG Capital Partners | Series A |
| MonteSacro Capital Partners | Series A |
| Hatteras Venture Partners | Series D, Series C, Series B |
| Health Enterprise Partners | Series D, Series C |
| Allumia Ventures | Series D, Series C |
| TripleTree | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 84% MoM.
- Mar 8, 2022
$26M round led by TripleTree, Truehelm, and TT Capital Partners.
For institutional investors. Book with your work email.
Wildflower Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wildflower Health's valuation, stock price, and market status.
Is Wildflower Health a public or private company?
Wildflower Health is a private company.
What is the current stock price of Wildflower Health?
Wildflower Health is a private company, so its shares have no public market price. Caplight tracks Wildflower Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wildflower Health worth (valuation)?
Valuation information for Wildflower Health is not publicly available.
Can I buy Wildflower Health stock?
Wildflower Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wildflower Health's last funding round?
Wildflower Health's most recent funding round was Series D on March 8, 2022.
Who are the main investors in Wildflower Health?
Key investors in Wildflower Health include KMG Capital Partners, Hatteras Venture Partners, Health Enterprise Partners, TripleTree, TT Capital Partners.
Will Wildflower Health IPO soon?
No public IPO plans have been announced for Wildflower Health.
How can I track Wildflower Health secondary market activity?
Caplight tracks bids, offers, and trades in Wildflower Health's shares on secondary markets.